Search Thermo Fisher Scientific
MA5-15674 targets THAP11 in indirect ELISA, FACS, IF, IHC, and WB applications and shows reactivity with Human samples.
The MA5-15674 immunogen is purified recombinant fragment of human THAP11 expressed in E. Coli.
MA5-15674 detects THAP11 which has a predicted molecular weight of approximately 44kDa.
This gene encodes two proteins, the SART1protein expressed in the nucleus of the majority of proliferating cells, and the SART1protein expressed in the cytosol of epithelial cancers. The SART1protein is translated by the mechanism of -1 frameshifting during posttranscriptional regulation; its full-length sequence is not published yet. The two encoded proteins are thought to be involved in the regulation of proliferation. Both proteins have tumor-rejection antigens. The SART1protein possesses tumor epitopes capable of inducing HLA-A2402-restricted cytotoxic T lymphocytes in cancer patients. This SART1antigen may be useful in specific immunotherapy for cancer patients and may serve as a paradigmatic tool for the diagnosis and treatment of patients with atopy. The SART1protein is found to be essential for the recruitment of the tri-snRNP to the pre-spliceosome in the spliceosome assembly pathway.
仅用于科研。不用于诊断过程。未经明确授权不得转售。
蛋白别名: THAP domain-containing protein 11
基因别名: CTG-B43a; CTG-B45d; HRIHFB2206; RONIN; THAP11
UniProt ID: (Human) Q96EK4
Entrez Gene ID: (Human) 57215